Aura Biosciences, Inc.
NASDAQ:AURA · NASDAQ Global Market
-$0.09 today
Vol 1.25M · Avg 0.52M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+3.09%
Period High
$8.90
Period Low
$4.97
Latest
$6.34
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$848.51M
Design Therapeutics, Inc.
NASDAQ:DSGN
$756.35M
Solid Biosciences Inc.
NASDAQ:SLDB
$590.95M
Annexon, Inc.
NASDAQ:ANNX
$585.79M
DBV Technologies S.A.
NASDAQ:DBVT
$385.71M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$351.06M
Altimmune, Inc.
NASDAQ:ALT
$239.62M
Quantum-Si incorporated
NASDAQ:QSI
$194.84M
Korro Bio, Inc.
NASDAQ:KRRO
$125.96M
enGene Holdings Inc.
NASDAQ:ENGN
$88.06M
What is the latest AURA filing?
The latest filing shown is PRE 14A dated Jun 17, 2026.
How many recent filings does AURA have?
Intrinsic Alpha currently shows 20 recent filings for AURA.
Explore More
Continue the stock analysis
Jump to another research area for this company.